GUTSFRACTYL HEALTH, INC.
Health Care
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents revised up 6.3% for Q1 2024
This is the 8th largest revision in GUTS's history.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Q1 2024
As reported
$67.5MRestated
$71.7M6.3%
Verify against SEC filingsShow
As reported$67.5M
Accepted 2025-05-130000950170-25-070275
Restated$71.7M
Accepted 2026-05-120001193125-26-219373
CashAndEquivalents · reported 3 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get an alert the next time GUTS — or any company on your watchlist — restates a number. Every alert lands with the diff and its source filing.